Last €20.93 EUR
Change Today +0.24 / 1.16%
Volume 29.1K
AFX On Other Exchanges
As of 1:55 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

carl zeiss meditec ag - br (AFX) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/15/13 - €26.96
52 Week Low
03/14/14 - €19.47
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for CARL ZEISS MEDITEC AG - BR (AFX)

Related News

No related news articles were found.

carl zeiss meditec ag - br (AFX) Related Businessweek News

No Related Businessweek News Found

carl zeiss meditec ag - br (AFX) Details

Carl Zeiss Meditec AG operates as a medical technology company worldwide. It operates through Ophthalmic Systems, Surgical Ophthalmology, and Microsurgery segments. The company provides various products and services in the fields of ophthalmology and optometry; neurosurgery; ear, nose, and throat; spine; plastic and reconstructive (P&R); dentistry; gynecology; and oncology. The company’s ophthalmic equipment and systems handle the diagnosis, progress monitoring, treatment, and follow-up treatment of ophthalmic syndromes comprising vision defects (refraction), cataract, glaucoma, and retinal disorders. It also provides ophthalmic implants consisting of intraocular lenses; and disposables. In addition, the company offers visualization products, such as surgical microscopes and loupes for neuro, spine, P&R, and dental surgeries, as well as for ear, nose, and throat surgeries; intraoperative radiation therapy devices to treat various tumors; and colposcopes for gynecological applications. Carl Zeiss Meditec AG serves physicians in various fields and hospitals through a distribution network of 40 sales companies and 100 agencies. The company was founded in 2002 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.

2,631 Employees
Last Reported Date: 01/30/14
Founded in 2002

carl zeiss meditec ag - br (AFX) Top Compensated Officers

Chairman of Management Board, Chief Executive...
Total Annual Compensation: €470.8K
Chief Financial Officer and Member of Managem...
Total Annual Compensation: €379.9K
Chief Sales Officer and Member of Management ...
Total Annual Compensation: €393.5K
Compensation as of Fiscal Year 2013.

carl zeiss meditec ag - br (AFX) Key Developments

Carl Zeiss Meditec AG Announces Revenue Results for the First Quarter of 2013

Carl Zeiss Meditec AG announced revenue results for the first quarter of 2013. For the quarter, the company reported revenue of EUR 212.3 million, 3% lower than in the same quarter of the previous year. Earnings before interest and taxes fell to EUR 26.5 million against EUR 31.3 million a year ago.

Carl Zeiss Meditec AG to Report Q1, 2014 Results on Feb 13, 2014

Carl Zeiss Meditec AG announced that they will report Q1, 2014 results on Feb 13, 2014

Carl Zeiss Meditec AG, Annual General Meeting, Mar 04, 2014

Carl Zeiss Meditec AG, Annual General Meeting, Mar 04, 2014.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFX:GR €20.93 EUR +0.24

AFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ellex Medical Lasers Ltd A$0.34 AUD 0.00
Iridex Corp $8.97 USD +0.01
Lightpath Technologies Inc $1.49 USD -0.02
Synergetics USA Inc $3.31 USD -0.06
Topcon Corp ¥1,740 JPY +50.00
View Industry Companies

Industry Analysis


Industry Average

Valuation AFX Industry Range
Price/Earnings 18.9x
Price/Sales 1.9x
Price/Book 2.4x
Price/Cash Flow 18.9x
TEV/Sales 1.8x

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CARL ZEISS MEDITEC AG - BR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at